$BESC.OB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Oncologix Tech Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Oncologix Tech Inc.. Get notifications about new insider transactions in Oncologix Tech Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 02 2014 | BESC.OB | Oncologix Tech Inc ... | HART VICKIE | Option Exercise | A | 0.02 | 1,600,000 | 24,000 | 1,600,000 | ||
| Jan 02 2014 | BESC.OB | Oncologix Tech Inc ... | Erwin Roy Wayne | CEO, Chairman | Option Exercise | A | 0.00 | 10,000 | 16 | 58,470,000 | |
| Jan 02 2014 | BESC.OB | Oncologix Tech Inc ... | Erwin Roy Wayne | CEO, Chairman | Option Exercise | A | 0.02 | 2,400,000 | 36,000 | 58,464,000 | |
| Jan 02 2014 | BESC.OB | Oncologix Tech Inc ... | Kramarz Michael Anthony | CFO | Option Exercise | A | 0.02 | 2,100,000 | 31,500 | 2,112,750 | |
| Jan 02 2014 | BESC.OB | Oncologix Tech Inc ... | Griffith Barry K | Director | Option Exercise | A | 0.02 | 10,000 | 160 | 35,000 | |
| Sep 13 2013 | BESC.OB | Oncologix Tech Inc ... | Schreifels Donald | 10% Owner | Option Exercise | A | 0.02 | 1,500,000 | 22,500 | 7,500,000 | |
| Sep 13 2013 | BESC.OB | Oncologix Tech Inc ... | Schreifels Donald | 10% Owner | Buy | P | 0.01 | 1,500,000 | 10,050 | 17,993,570 | 16.5 M to 18 M (+9.09 %) |
| Feb 11 2013 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | CEO and President | Option Exercise | C | 0.01 | 1,024,164 | 10,242 | 3,500 | |
| Feb 11 2013 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | CEO and President | Option Exercise | J | 0.01 | 1,024,164 | 10,242 | 1,027,664 | |
| Feb 11 2013 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | CEO and President | Grant | A | 0.01 | 1,024,164 | 10,242 | 7,243,059 | 6.2 M to 7.2 M (+16.47 %) |
| Aug 31 2012 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | CEO and President | Option Exercise | C | 0.02 | 2,250,000 | 45,000 | 3,500 | |
| Aug 31 2012 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | CEO and President | Gift | G | 0.02 | 500,000 | 10,000 | 6,218,895 | 6.7 M to 6.2 M (-7.44 %) |
| Aug 31 2012 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | CEO and President | Grant | A | 0.02 | 2,276,182 | 45,524 | 6,718,895 | 4.4 M to 6.7 M (+51.23 %) |
| Aug 24 2012 | BESC.OB | Oncologix Tech Inc ... | Oncologix Tech Inc. | CEO and President | Option Exercise | J | 0.04 | 2,250,000 | 90,000 | 2,253,500 | |
| Jan 27 2012 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | CEO and President | Option Exercise | D | 0.04 | 250,000 | 10,000 | 3,500 | |
| Jan 27 2012 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | CEO and President | Option Exercise | D | 0.04 | 250,000 | 10,000 | 253,500 | |
| Dec 28 2011 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | CEO and President | Option Exercise | J | 0.04 | 250,000 | 10,000 | 503,500 | |
| Oct 11 2011 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | CEO and President | Option Exercise | J | 0.04 | 1,778,193 | 71,128 | 253,500 | |
| Oct 11 2011 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | CEO and President | Option Exercise | C | 0.04 | 1,778,193 | 71,128 | 3,500 | |
| Oct 11 2011 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | CEO and President | Option Exercise | J | 0.04 | 1,778,193 | 71,128 | 1,781,693 | |
| Oct 11 2011 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | CEO and President | Gift | G | 0.04 | 1,778,193 | 71,128 | 4,442,713 | 6.2 M to 4.4 M (-28.58 %) |
| Oct 11 2011 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | CEO and President | Grant | A | 0.04 | 1,778,193 | 71,128 | 6,220,906 | 4.4 M to 6.2 M (+40.02 %) |
| Jun 07 2011 | BESC.OB | Oncologix Tech Inc ... | Griffith Barry K | Director | Buy | P | 0.12 | 100,000 | 12,000 | 200,000 | 100 K to 200 K (+100.00 %) |
| Jun 03 2011 | BESC.OB | Oncologix Tech Inc ... | Griffith Barry K | Director | Buy | P | 0.09 | 100,000 | 9,000 | 100,000 | 0 to 100 K |
| Jan 28 2011 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | CEO & President | Option Exercise | A | 0.03 | 14,000 | 420 | 14,000 | |
| Jan 28 2011 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | CEO & President | Option Exercise | D | 0.17 | 50,000 | 8,500 | 0 | |
| Jan 28 2011 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | CEO & President | Option Exercise | D | 0.17 | 20,000 | 3,400 | 50,000 | |
| Jan 28 2011 | BESC.OB | Oncologix Tech Inc ... | LINDSTROM JUDY | Option Exercise | A | 0.03 | 20,000 | 600 | 20,000 | ||
| Jan 28 2011 | BESC.OB | Oncologix Tech Inc ... | LINDSTROM JUDY | Option Exercise | D | 0.40 | 100,000 | 40,000 | 0 | ||
| Jan 28 2011 | BESC.OB | Oncologix Tech Inc ... | Kramarz Michael Anthony | CFO | Option Exercise | A | 0.03 | 51,000 | 1,530 | 51,000 | |
| Jan 28 2011 | BESC.OB | Oncologix Tech Inc ... | Kramarz Michael Anthony | CFO | Option Exercise | D | 0.40 | 100,000 | 40,000 | 0 | |
| Jan 28 2011 | BESC.OB | Oncologix Tech Inc ... | Kramarz Michael Anthony | CFO | Option Exercise | D | 0.17 | 20,000 | 3,300 | 100,000 | |
| Jan 28 2011 | BESC.OB | Oncologix Tech Inc ... | Kramarz Michael Anthony | CFO | Option Exercise | D | 0.23 | 50,000 | 11,500 | 120,000 | |
| Jan 28 2011 | BESC.OB | Oncologix Tech Inc ... | Kramarz Michael Anthony | CFO | Option Exercise | D | 0.50 | 30,000 | 15,000 | 170,000 | |
| Jan 28 2011 | BESC.OB | Oncologix Tech Inc ... | Kramarz Michael Anthony | CFO | Option Exercise | D | 0.53 | 10,000 | 5,300 | 200,000 | |
| Jan 28 2011 | BESC.OB | Oncologix Tech Inc ... | Kramarz Michael Anthony | CFO | Option Exercise | D | 1.33 | 45,000 | 59,850 | 210,000 | |
| Jan 28 2011 | BESC.OB | Oncologix Tech Inc ... | Griffith Barry K | Director | Option Exercise | A | 0.03 | 100,000 | 3,000 | 100,000 | |
| Jan 28 2011 | BESC.OB | Oncologix Tech Inc ... | Griffith Barry K | Director | Option Exercise | D | 0.24 | 10,000 | 2,400 | 0 | |
| Jan 28 2011 | BESC.OB | Oncologix Tech Inc ... | Griffith Barry K | Director | Option Exercise | D | 0.40 | 100,000 | 40,000 | 10,000 | |
| Jan 28 2011 | BESC.OB | Oncologix Tech Inc ... | Griffith Barry K | Director | Option Exercise | D | 0.45 | 10,000 | 4,500 | 110,000 | |
| Jan 28 2011 | BESC.OB | Oncologix Tech Inc ... | Griffith Barry K | Director | Option Exercise | D | 0.40 | 300,000 | 120,000 | 120,000 | |
| Jan 28 2011 | BESC.OB | Oncologix Tech Inc ... | Griffith Barry K | Director | Option Exercise | D | 0.24 | 10,000 | 2,400 | 420,000 | |
| Jan 28 2011 | BESC.OB | Oncologix Tech Inc ... | Griffith Barry K | Director | Option Exercise | D | 0.23 | 50,000 | 11,500 | 430,000 | |
| Jan 28 2011 | BESC.OB | Oncologix Tech Inc ... | Griffith Barry K | Director | Option Exercise | D | 0.23 | 20,000 | 4,600 | 480,000 | |
| Dec 31 2009 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | CEO & President | Gift | G | 0.05 | 4,759,452 | 237,973 | 17,770,850 | 22.5 M to 17.8 M (-21.12 %) |
| Oct 10 2008 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | 10% Owner | Grant | A | 0.05 | 1,500,000 | 75,000 | 24,984,852 | 23.5 M to 25 M (+6.39 %) |
| Aug 07 2008 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | 10% Owner | Grant | A | 0.01 | 1,500,000 | 15,000 | 23,984,852 | 22.5 M to 24 M (+6.67 %) |
| Aug 14 2008 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | 10% Owner | Gift | G | 0.05 | 500,000 | 25,000 | 23,484,852 | 24 M to 23.5 M (-2.08 %) |
| Jun 18 2008 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | Option Exercise | C | 0.05 | 1,000,000 | 50,000 | 75,000 | ||
| Jun 18 2008 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | Option Exercise | J | 0.05 | 750,000 | 37,500 | 1,075,000 | ||
| Jun 18 2008 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | Grant | A | 0.00 | 1,000,000 | 0 | 1,711,992 | 712 K to 1.7 M (+140.45 %) | |
| Jun 13 2008 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | 10% Owner | Option Exercise | A | 0.15 | 402,100 | 60,315 | 512,100 | |
| Jun 13 2008 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | 10% Owner | Option Exercise | C | 0.05 | 13,109,000 | 655,450 | 110,000 | |
| Jun 13 2008 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | 10% Owner | Option Exercise | J | 0.05 | 8,605,250 | 430,263 | 13,219,000 | |
| Jun 13 2008 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | 10% Owner | Grant | A | 0.05 | 13,109,000 | 655,450 | 22,484,852 | 9.4 M to 22.5 M (+139.82 %) |
| Jun 09 2008 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | Option Exercise | J | 0.15 | 3,833,333 | 575,000 | 4,613,750 | ||
| Jun 09 2008 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | Option Exercise | C | 0.05 | 4,759,452 | 237,973 | 780,417 | ||
| Jun 09 2008 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | Option Exercise | J | 0.05 | 4,092,785 | 204,639 | 5,539,869 | ||
| Jun 09 2008 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | Grant | A | 0.05 | 4,759,452 | 237,973 | 9,375,852 | 4.6 M to 9.4 M (+103.10 %) | |
| Jan 04 2008 | BESC.OB | Oncologix Tech Inc ... | Lowe Adam | Chief Operating Off ... | Option Exercise | A | 0.24 | 10,000 | 2,400 | 30,000 | |
| Jan 04 2008 | BESC.OB | Oncologix Tech Inc ... | LINDSTROM JUDY | Director | Option Exercise | A | 0.24 | 10,000 | 2,400 | 130,000 | |
| Jan 04 2008 | BESC.OB | Oncologix Tech Inc ... | Kurtzman Steven | Director | Option Exercise | A | 0.24 | 10,000 | 2,400 | 430,000 | |
| Jan 04 2008 | BESC.OB | Oncologix Tech Inc ... | Kennedy Andrew | Chief Medical Offic ... | Option Exercise | A | 0.24 | 10,000 | 2,400 | 40,000 | |
| Jan 04 2008 | BESC.OB | Oncologix Tech Inc ... | Griffith Barry K | Director | Option Exercise | A | 0.24 | 10,000 | 2,400 | 500,000 | |
| Jan 04 2008 | BESC.OB | Oncologix Tech Inc ... | Green Andrew | Chief Executive Off ... | Option Exercise | A | 0.24 | 10,000 | 2,400 | 40,000 | |
| Jan 02 2008 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | Sell | S | 0.08 | 300,000 | 23,100 | 4,616,400 | 4.9 M to 4.6 M (-6.10 %) | |
| Dec 03 2007 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | Director | Option Exercise | D | 0.20 | 500,000 | 100,000 | 435,000 | |
| Sep 06 2007 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | Director | Option Exercise | A | 0.20 | 750,000 | 150,000 | 935,000 | |
| Jul 13 2007 | BESC.OB | Oncologix Tech Inc ... | Griffith Barry K | Director | Option Exercise | A | 0.40 | 100,000 | 40,000 | 490,000 | |
| Jun 27 2007 | BESC.OB | Oncologix Tech Inc ... | Lowe Adam | Chief Operating Off ... | Option Exercise | A | 0.38 | 20,000 | 7,600 | 20,000 | |
| Feb 09 2007 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | President | Sell | S | 0.48 | 15,000 | 7,200 | 711,992 | 727 K to 712 K (-2.06 %) |
| Feb 02 2007 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | President | Sell | S | 0.47 | 8,000 | 3,760 | 726,992 | 735 K to 727 K (-1.09 %) |
| Jan 03 2007 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | Director | Option Exercise | A | 0.45 | 10,000 | 4,500 | 1,627,084 | |
| Jan 03 2007 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | President | Option Exercise | A | 0.45 | 10,000 | 4,500 | 195,000 | |
| Jan 03 2007 | BESC.OB | Oncologix Tech Inc ... | Griffith Barry K | Director | Option Exercise | A | 0.45 | 10,000 | 4,500 | 390,000 | |
| Jan 03 2007 | BESC.OB | Oncologix Tech Inc ... | Kennedy Andrew | Director | Option Exercise | A | 0.45 | 10,000 | 4,500 | 30,000 | |
| Jan 03 2007 | BESC.OB | Oncologix Tech Inc ... | Green Andrew | Director | Option Exercise | A | 0.45 | 10,000 | 4,500 | 30,000 | |
| Dec 19 2006 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | President | Option Exercise | D | 0.17 | 20,000 | 3,300 | 185,000 | |
| Dec 19 2006 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | President | Grant | A | 0.45 | 20,000 | 9,000 | 754,992 | 735 K to 755 K (+2.72 %) |
| Jul 28 2006 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | Director | Option Exercise | A | 0.35 | 571,429 | 200,000 | 1,488,902 | |
| Mar 24 2006 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | President | Option Exercise | A | 0.40 | 100,000 | 40,000 | 205,000 | |
| Mar 24 2006 | BESC.OB | Oncologix Tech Inc ... | Griffith Barry K | Director | Option Exercise | A | 0.40 | 300,000 | 120,000 | 380,000 | |
| Mar 24 2006 | BESC.OB | Oncologix Tech Inc ... | Kramarz Michael Anthony | CFO & Secretary | Option Exercise | A | 0.40 | 100,000 | 40,000 | 255,000 | |
| Jan 19 2006 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | President | Sell | D | 0.25 | 18,500 | 4,625 | 891,695 | 910.2 K to 891.7 K (-2.03 %) |
| Jan 19 2006 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | President | Sell | D | 0.24 | 25,000 | 6,000 | 910,195 | 935.2 K to 910.2 K (-2.67 %) |
| Oct 18 2005 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | President | Option Exercise | D | 0.22 | 36,667 | 8,067 | 95,000 | |
| Oct 18 2005 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | President | Grant | A | 0.22 | 36,667 | 8,067 | 918,352 | 881.7 K to 918.4 K (+4.16 %) |
| Jul 06 2005 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | Director | Option Exercise | D | 0.15 | 197,000 | 29,550 | 905,329 | |
| Jul 06 2005 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | Director | Option Exercise | D | 0.15 | 34,754 | 5,213 | 1,102,329 | |
| Jul 06 2005 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | Director | Option Exercise | D | 0.15 | 194,400 | 29,160 | 1,137,083 | |
| Jul 06 2005 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | Director | Grant | A | 0.15 | 197,000 | 29,550 | 3,163,768 | 3 M to 3.2 M (+6.64 %) |
| Jul 06 2005 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | Director | Grant | A | 0.15 | 34,754 | 5,213 | 2,966,768 | 2.9 M to 3 M (+1.19 %) |
| Jul 06 2005 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | Director | Grant | A | 0.15 | 194,400 | 29,160 | 2,932,014 | 2.7 M to 2.9 M (+7.10 %) |
| Jul 05 2005 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | President | Option Exercise | D | 0.15 | 4,232 | 635 | 131,667 | |
| Jul 05 2005 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | President | Grant | A | 0.15 | 4,232 | 635 | 881,685 | 877.5 K to 881.7 K (+0.48 %) |
| Jun 27 2005 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | President | Option Exercise | D | 0.15 | 83,333 | 12,500 | 135,899 | |
| Jun 27 2005 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | President | Grant | A | 0.15 | 83,333 | 12,500 | 737,593 | 654.3 K to 737.6 K (+12.74 %) |
| May 03 2005 | BESC.OB | Oncologix Tech Inc ... | BOURKE RICHARD | Director | Buy | S | 0.15 | 10,000 | 1,500 | 307,960 | 298 K to 308 K (+3.36 %) |
| Apr 06 2005 | BESC.OB | Oncologix Tech Inc ... | BOURKE RICHARD | Director | Buy | S | 0.19 | 10,000 | 1,900 | 317,960 | 308 K to 318 K (+3.25 %) |
| Apr 06 2005 | BESC.OB | Oncologix Tech Inc ... | BOURKE RICHARD | Director | Buy | S | 0.19 | 10,000 | 1,900 | 327,960 | 318 K to 328 K (+3.15 %) |
| Mar 29 2005 | BESC.OB | Oncologix Tech Inc ... | Wilbore Kelvin | Chief Operations Of ... | Option Exercise | A | 0.17 | 20,000 | 3,300 | 349,300 | |
| Mar 29 2005 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | President | Option Exercise | A | 0.17 | 20,000 | 3,300 | 219,232 | |
| Mar 23 2005 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | Director | Option Exercise | A | 0.24 | 10,000 | 2,400 | 741,452 | |
| Mar 24 2005 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | Director | Option Exercise | A | 0.12 | 916,667 | 110,000 | 1,658,119 | |
| Mar 29 2005 | BESC.OB | Oncologix Tech Inc ... | Kramarz Michael Anthony | Chief Financial Off ... | Option Exercise | A | 0.17 | 20,000 | 3,300 | 155,000 | |
| Jan 25 2005 | BESC.OB | Oncologix Tech Inc ... | BOURKE RICHARD | Director | Buy | S | 0.21 | 20,000 | 4,100 | 337,960 | 318 K to 338 K (+6.29 %) |
| Mar 23 2005 | BESC.OB | Oncologix Tech Inc ... | BOURKE RICHARD | Director | Option Exercise | A | 0.24 | 10,000 | 2,400 | 104,560 | |
| Mar 23 2005 | BESC.OB | Oncologix Tech Inc ... | MESSINA MARCO | Director | Option Exercise | A | 0.24 | 10,000 | 2,400 | 85,000 | |
| Jan 20 2005 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | President | Option Exercise | A | 0.30 | 4,232 | 1,270 | 199,232 | |
| Jan 20 2005 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | President | Option Exercise | C | 0.30 | 12,696 | 3,809 | 195,000 | |
| Jan 20 2005 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | President | Grant | A | 0.30 | 8,464 | 2,539 | 654,260 | 662.7 K to 654.3 K (-1.28 %) |
| Jan 03 2005 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | President | Sell | D | 0.23 | 16,900 | 3,887 | 645,796 | 662.7 K to 645.8 K (-2.55 %) |
| Dec 22 2004 | BESC.OB | Oncologix Tech Inc ... | MESSINA MARCO | Director | Grant | A | 0.22 | 25,000 | 5,500 | 202,046 | 177 K to 202 K (+14.12 %) |
| Dec 22 2004 | BESC.OB | Oncologix Tech Inc ... | MESSINA MARCO | Director | Sell | D | 0.22 | 11,364 | 2,500 | 177,046 | 188.4 K to 177 K (-6.03 %) |
| Dec 22 2004 | BESC.OB | Oncologix Tech Inc ... | MESSINA MARCO | Director | Grant | A | 0.27 | 17,052 | 4,604 | 188,410 | 171.4 K to 188.4 K (+9.95 %) |
| Dec 22 2004 | BESC.OB | Oncologix Tech Inc ... | MESSINA MARCO | Director | Sell | D | 0.27 | 7,499 | 2,025 | 171,358 | 178.9 K to 171.4 K (-4.19 %) |
| Dec 22 2004 | BESC.OB | Oncologix Tech Inc ... | MESSINA MARCO | Director | Grant | A | 0.24 | 20,921 | 5,021 | 178,857 | 157.9 K to 178.9 K (+13.25 %) |
| Dec 22 2004 | BESC.OB | Oncologix Tech Inc ... | MESSINA MARCO | Director | Sell | D | 0.21 | 11,905 | 2,500 | 157,936 | 169.8 K to 157.9 K (-7.01 %) |
| Dec 22 2004 | BESC.OB | Oncologix Tech Inc ... | MESSINA MARCO | Director | Grant | A | 0.23 | 21,552 | 4,957 | 169,841 | 148.3 K to 169.8 K (+14.53 %) |
| Dec 22 2004 | BESC.OB | Oncologix Tech Inc ... | MESSINA MARCO | Director | Grant | A | 0.24 | 20,921 | 5,021 | 148,289 | 127.4 K to 148.3 K (+16.43 %) |
| Dec 02 2004 | BESC.OB | Oncologix Tech Inc ... | BOURKE RICHARD | Interin CEO until 1 ... | Grant | A | 0.25 | 50,000 | 12,500 | 357,960 | 308 K to 358 K (+16.24 %) |
| Oct 22 2004 | BESC.OB | Oncologix Tech Inc ... | BOURKE RICHARD | Interim CEO | Grant | A | 0.25 | 50,000 | 12,500 | 307,960 | 258 K to 308 K (+19.38 %) |
| Sep 20 2004 | BESC.OB | Oncologix Tech Inc ... | MESSINA MARCO | Director | Grant | A | 0.21 | 11,905 | 2,500 | 127,368 | 115.5 K to 127.4 K (+10.31 %) |
| Sep 20 2004 | BESC.OB | Oncologix Tech Inc ... | BOURKE RICHARD | Interim CEO | Grant | A | 0.20 | 50,000 | 10,000 | 257,960 | 208 K to 258 K (+24.04 %) |
| Sep 02 2004 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | Director | Option Exercise | A | 0.30 | 10,193 | 3,058 | 731,452 | |
| Sep 02 2004 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | Director | Grant | A | 0.74 | 30,579 | 22,628 | 2,657,226 | 2.6 M to 2.7 M (+1.16 %) |
| Sep 02 2004 | BESC.OB | Oncologix Tech Inc ... | BOURKE RICHARD | Interim CEO | Option Exercise | A | 0.30 | 3,320 | 996 | 94,560 | |
| Sep 02 2004 | BESC.OB | Oncologix Tech Inc ... | BOURKE RICHARD | Interim CEO | Grant | A | 0.70 | 9,960 | 6,972 | 207,960 | 198 K to 208 K (+5.03 %) |
| Sep 02 2004 | BESC.OB | Oncologix Tech Inc ... | MESSINA MARCO | Director | Grant | A | 0.22 | 11,364 | 2,500 | 115,463 | 104.1 K to 115.5 K (+10.92 %) |
| Sep 02 2004 | BESC.OB | Oncologix Tech Inc ... | MESSINA MARCO | Director | Grant | A | 0.27 | 7,499 | 2,025 | 104,099 | 96.6 K to 104.1 K (+7.76 %) |
| Aug 27 2004 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | Director | Option Exercise | A | 0.30 | 24,561 | 7,368 | 700,873 | |
| Aug 27 2004 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | Director | Grant | A | 0.20 | 49,123 | 9,825 | 2,626,647 | 2.6 M to 2.6 M (+1.91 %) |
| Aug 27 2004 | BESC.OB | Oncologix Tech Inc ... | BOURKE RICHARD | Interim CEO | Option Exercise | A | 0.30 | 8,000 | 2,400 | 84,600 | |
| Aug 27 2004 | BESC.OB | Oncologix Tech Inc ... | BOURKE RICHARD | Interim CEO | Grant | A | 0.20 | 16,000 | 3,200 | 198,000 | 182 K to 198 K (+8.79 %) |
| Aug 25 2004 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | Director | Option Exercise | A | 0.17 | 50,000 | 8,500 | 581,400 | |
| Aug 25 2004 | BESC.OB | Oncologix Tech Inc ... | SILVERMAN ANTHONY | Director | Option Exercise | A | 0.17 | 20,000 | 3,400 | 531,400 | |
| Aug 16 2004 | BESC.OB | Oncologix Tech Inc ... | BOURKE RICHARD | Interim CEO | Grant | A | 0.20 | 50,000 | 10,000 | 182,000 | 132 K to 182 K (+37.88 %) |
| Aug 09 2004 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | Director | Option Exercise | A | 0.30 | 120,000 | 36,000 | 207,696 | |
| Aug 09 2004 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | Director | Option Exercise | C | 0.30 | 360,000 | 108,000 | 87,696 | |
| Aug 09 2004 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | Director | Grant | A | 0.30 | 240,000 | 72,000 | 662,696 | 422.7 K to 662.7 K (+56.78 %) |
| Jul 20 2004 | BESC.OB | Oncologix Tech Inc ... | BLANCHARD ROBERT A | Grant | A | 0.23 | 36,000 | 8,280 | 136,000 | 100 K to 136 K (+36.00 %) | |
| Jul 09 2004 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | Director | Option Exercise | C | 0.30 | 237,303 | 71,191 | 447,696 | |
| Jul 09 2004 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | Director | Grant | A | 0.30 | 262,695 | 78,809 | 422,696 | 160 K to 422.7 K (+164.18 %) |
| May 13 2004 | BESC.OB | Oncologix Tech Inc ... | BOURKE RICHARD | Director | Option Exercise | A | 0.27 | 1,600 | 432 | 76,600 | |
| Jun 30 2004 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | Director | Option Exercise | S | 0.30 | 75,000 | 22,500 | 684,999 | |
| Jun 30 2004 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | Director | Sell | S | 0.74 | 75,000 | 55,500 | 160,001 | 235 K to 160 K (-31.91 %) |
| Mar 16 2004 | BESC.OB | Oncologix Tech Inc ... | SCHLOZ STANLEY | Director | Grant | A | 0.30 | 84,000 | 25,200 | 319,001 | 235 K to 319 K (+35.74 %) |
| Mar 16 2004 | BESC.OB | Oncologix Tech Inc ... | BOURKE RICHARD | Director | Grant | A | 0.30 | 48,000 | 14,400 | 156,000 | 108 K to 156 K (+44.44 %) |
| Feb 20 2004 | BESC.OB | Oncologix Tech Inc ... | BLANCHARD ROBERT A | President & CEO | Grant | A | 0.25 | 100,000 | 25,000 | 100,000 | 0 to 100 K |
Page: 1